Abstract:BACKGROUND:Cancer-associated fibroblasts (CAFs) are a crucial component of the tumor microenvironment (TME) and play significant roles in tumor initiation, progression, and immune evasion. Despite this, the specific exosomal proteins derived from CAFs and their functions in esophageal squamous cell carcinoma (ESCC) remain unknown. Therefore, this study aims to investigate the impact and prognostic significance of CAFs-derived exosomal proteins in ESCC.MATERIALS AND METHODS:Exosomes obtained from CAFs and normal fibroblasts (NFs) were isolated using ultracentrifugation, and the protein expression profiles of the exosomes were analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Tumor proliferation was assessed using CCK-8 and colony formation assays, while cell invasion and migration were evaluated using transwell assays. Lasso regression analysis was employed to establish a signature based on CAFs-derived exosomal proteins using the TCGA database. The immunological and prognostic roles of this signature were comprehensively investigated through survival analysis, gene set enrichment analysis (GSEA), immune analysis, immunotherapy response analysis, and drug sensitivity analysis. The GSE160269 dataset was utilized for single-cell transcriptome analysis to further elucidate the role of the signature in the TME. Additionally, cDNA microarray analysis was utilized to validate the prognostic value of the signature.RESULTS:Our findings demonstrate that exosomes derived from CAFs significantly enhance the proliferation, invasion, and migration of esophageal cancer cells. We identified 842 differentially expressed exosomal proteins through LC-MS/MS analysis, and two key proteins were utilized to establish a risk signature. Survival analysis revealed a significantly worse prognosis in the high-risk group, with multivariate analysis indicating that the risk score serves as an independent prognostic factor. Moreover, we observed a significant correlation between the risk score and immune cell infiltration, immunotherapy response, and sensitivity to chemotherapeutic treatments in the study population. Lastly, single-cell transcriptome analysis further revealed the expression patterns of TNFRSF10B and ILF3 in different cell subpopulations.CONCLUSION:In conclusion, our study has successfully established a robust prognostic signature based on CAFs-derived exosomal proteins, which can serve as a reliable biomarker for predicting prognosis and evaluating the immune microenvironment in ESCC.

Prognostic Value of Association of OCT4 with LEF1 Expression in Esophageal Squamous Cell Carcinoma and Their Impact on Epithelial‐mesenchymal Transition, Invasion, and Migration

The Transcription Factor LEF1 Promotes Tumorigenicity and Activates the TGF-β Signaling Pathway in Esophageal Squamous Cell Carcinoma

Carcinogenesis promotion in oral squamous cell carcinoma: KDM4A complex-mediated gene transcriptional suppression by LEF1

Oct4 Positively Regulates Survivin Expression To Promote Cancer Cell Proliferation And Leads To Poor Prognosis In Esophageal Squamous Cell Carcinoma

Clinicopathological Significance Of Sox4, Beta-Catenin, And Tcf4 Expression In Esophageal Squamous Cell Carcinoma

Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma

Transcriptional factor OCT4 promotes esophageal cancer metastasis by inducing epithelial-mesenchymal transition through VEGF-C/VEGFR-3 signaling pathway.

Expression of OCT4 in Human Esophageal Squamous Cell Carcinoma is Significantly Associated with Poorer Prognosis

14P High CMTM6 and PD-L1 co-expression predict metastasis and poor prognosis in oesophageal squamous cell carcinoma

Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma.

LINC00958 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma cells

MiR-34a-5p Inhibits Proliferation, Migration, Invasion and Epithelial-mesenchymal Transition in Esophageal Squamous Cell Carcinoma by Targeting LEF1 and Inactivation of the Hippo-YAP1/TAZ Signaling Pathway

Inhibition of SALL4 Reduces Tumorigenicity Involving Epithelial-Mesenchymal Transition Via Wnt/β-catenin Pathway in Esophageal Squamous Cell Carcinoma

Prognostic and Immunological Role of Cancer-Associated Fibroblasts-Derived Exosomal Protein in Esophageal Squamous Cell Carcinoma.

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

LEF1/Id3/HRAS Axis Promotes the Tumorigenesis and Progression of Esophageal Squamous Cell Carcinoma.

EXPREESION OF SOX4 SIGNIFICANTLY PREDICTS THE RISK OF LYMPH NODE METASTASIS FOR PATIENTS WITH EARLY-STAGE ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Expression of SOX4 Significantly Predicts the Risk of Lymph Node Metastasis for Patients With Early-Stage Esophageal Squamous Cell Carcinoma

Prognostic value of tumor‐infiltrating lymphocytes and PD‐L1 expression in esophageal squamous cell carcinoma

Prognostic value of Nrf2/HO-1 expression and its correlation with occurrence in esophageal squamous cell carcinoma

Clinical Significance of LOXL4 Expression and Features of LOXL4-associated Protein–protein Interaction Network in Esophageal Squamous Cell Carcinoma